Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.64) by 17.19 percent. This is a 29.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $88.71 million which beat the analyst consensus estimate of $86.97 million by 2.00 percent. This is a 24.08 percent increase over sales of $71.50 million the same period last year.